cerivastatin, an HMG-CoA reductase inhibitor (Baycol) withdrawn from the market in August 2001 after several cases of fatal rhabdomyolysis.
cerivastatin, an HMG-CoA reductase inhibitor (Baycol) withdrawn from the market in August 2001 after several cases of fatal rhabdomyolysis.